CPRX News

Catalyst Pharmaceutical Partners, a pharmaceutical company developing prescription drugs to treat addiction, priced 3.35 million shares at $6. This came after the company lowered the proposed price to $6 from its originally proposed $11-$13 range on Tuesday. ...read more

Catalyst Pharmaceutical Partners, a pharmaceutical company developing prescription drugs to treat addiction, announced that it now plans to offer 3.35 million shares at $6. The company originally planned to offer 3 million shares at a range of $11-$13. First...read more

Catalyst Pharmaceutical Partners, a pharmaceutical company developing prescription drugs to treat addiction, set the terms for its IPO on Wednesday. The Florida-based company plans to offer 3 million shares at a range of $11-$13. The deal has a proposed...read more

Catalyst Pharmaceutical Partners, a pharmaceutical company developing prescription drugs to treat addiction, filed for its IPO on Tuesday. First Albany and Stifel Nicolaus are set to manage the deal. Terms and timing have yet to be announced....read more